Endogenous opioid activity is associated with obsessive-compulsive symptomology in individuals with a family history of alcoholism

Deborah L. Mangold, Mark Peyrot, Paul Giggey, Gary S Wand

Research output: Contribution to journalArticle

Abstract

Endogenous opioid activity has been associated with the regulation of mood and inhibition of the hypothalamic-pituitary-adrenal (HPA) axis. We assessed differences in psychological symptomology and naloxone sensitivity in non-alcoholic males and females with a family history of alcoholism (FHP) and without a family history of alcoholism (FHN). This was followed by assessment of the association between naloxone sensitivity and psychological symptomology. Psychological symptomology was measured using the Revised Symptom Checklist (SCL-90-R) during enrollment. Adrenocorticotropin was measured following intravenous administration of naloxone/placebo. FHP males reported more obsessive-compulsive symptomology as well as increased sensitivity to naloxone relative to other groups. A positive association was observed between degree of obsessive-compulsive symptomology and naloxone sensitivity, and the association was strongest among FHP males. These findings suggest that the increased risk of alcoholism in FHP subjects (especially males) may be associated with altered opioid activity, which is expressed through an elevated level of obsessive compulsive symptomology. Copyright (C) 2000 American College of Neuropsychopharmacology.

Original languageEnglish (US)
Pages (from-to)595-607
Number of pages13
JournalNeuropsychopharmacology
Volume22
Issue number6
DOIs
StatePublished - Jun 2000

Fingerprint

Naloxone
Opioid Analgesics
Alcoholism
Psychology
Checklist
Intravenous Administration
Adrenocorticotropic Hormone
Placebos

Keywords

  • Adrenocorticotropin
  • Alcoholism
  • Hypothalamic-Pituitary-Adrenal Axis
  • Naloxone
  • Opioids

ASJC Scopus subject areas

  • Pharmacology

Cite this

Endogenous opioid activity is associated with obsessive-compulsive symptomology in individuals with a family history of alcoholism. / Mangold, Deborah L.; Peyrot, Mark; Giggey, Paul; Wand, Gary S.

In: Neuropsychopharmacology, Vol. 22, No. 6, 06.2000, p. 595-607.

Research output: Contribution to journalArticle

@article{d36344b4877541728663555cf59ff257,
title = "Endogenous opioid activity is associated with obsessive-compulsive symptomology in individuals with a family history of alcoholism",
abstract = "Endogenous opioid activity has been associated with the regulation of mood and inhibition of the hypothalamic-pituitary-adrenal (HPA) axis. We assessed differences in psychological symptomology and naloxone sensitivity in non-alcoholic males and females with a family history of alcoholism (FHP) and without a family history of alcoholism (FHN). This was followed by assessment of the association between naloxone sensitivity and psychological symptomology. Psychological symptomology was measured using the Revised Symptom Checklist (SCL-90-R) during enrollment. Adrenocorticotropin was measured following intravenous administration of naloxone/placebo. FHP males reported more obsessive-compulsive symptomology as well as increased sensitivity to naloxone relative to other groups. A positive association was observed between degree of obsessive-compulsive symptomology and naloxone sensitivity, and the association was strongest among FHP males. These findings suggest that the increased risk of alcoholism in FHP subjects (especially males) may be associated with altered opioid activity, which is expressed through an elevated level of obsessive compulsive symptomology. Copyright (C) 2000 American College of Neuropsychopharmacology.",
keywords = "Adrenocorticotropin, Alcoholism, Hypothalamic-Pituitary-Adrenal Axis, Naloxone, Opioids",
author = "Mangold, {Deborah L.} and Mark Peyrot and Paul Giggey and Wand, {Gary S}",
year = "2000",
month = "6",
doi = "10.1016/S0893-133X(99)00149-9",
language = "English (US)",
volume = "22",
pages = "595--607",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Endogenous opioid activity is associated with obsessive-compulsive symptomology in individuals with a family history of alcoholism

AU - Mangold, Deborah L.

AU - Peyrot, Mark

AU - Giggey, Paul

AU - Wand, Gary S

PY - 2000/6

Y1 - 2000/6

N2 - Endogenous opioid activity has been associated with the regulation of mood and inhibition of the hypothalamic-pituitary-adrenal (HPA) axis. We assessed differences in psychological symptomology and naloxone sensitivity in non-alcoholic males and females with a family history of alcoholism (FHP) and without a family history of alcoholism (FHN). This was followed by assessment of the association between naloxone sensitivity and psychological symptomology. Psychological symptomology was measured using the Revised Symptom Checklist (SCL-90-R) during enrollment. Adrenocorticotropin was measured following intravenous administration of naloxone/placebo. FHP males reported more obsessive-compulsive symptomology as well as increased sensitivity to naloxone relative to other groups. A positive association was observed between degree of obsessive-compulsive symptomology and naloxone sensitivity, and the association was strongest among FHP males. These findings suggest that the increased risk of alcoholism in FHP subjects (especially males) may be associated with altered opioid activity, which is expressed through an elevated level of obsessive compulsive symptomology. Copyright (C) 2000 American College of Neuropsychopharmacology.

AB - Endogenous opioid activity has been associated with the regulation of mood and inhibition of the hypothalamic-pituitary-adrenal (HPA) axis. We assessed differences in psychological symptomology and naloxone sensitivity in non-alcoholic males and females with a family history of alcoholism (FHP) and without a family history of alcoholism (FHN). This was followed by assessment of the association between naloxone sensitivity and psychological symptomology. Psychological symptomology was measured using the Revised Symptom Checklist (SCL-90-R) during enrollment. Adrenocorticotropin was measured following intravenous administration of naloxone/placebo. FHP males reported more obsessive-compulsive symptomology as well as increased sensitivity to naloxone relative to other groups. A positive association was observed between degree of obsessive-compulsive symptomology and naloxone sensitivity, and the association was strongest among FHP males. These findings suggest that the increased risk of alcoholism in FHP subjects (especially males) may be associated with altered opioid activity, which is expressed through an elevated level of obsessive compulsive symptomology. Copyright (C) 2000 American College of Neuropsychopharmacology.

KW - Adrenocorticotropin

KW - Alcoholism

KW - Hypothalamic-Pituitary-Adrenal Axis

KW - Naloxone

KW - Opioids

UR - http://www.scopus.com/inward/record.url?scp=0034006867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034006867&partnerID=8YFLogxK

U2 - 10.1016/S0893-133X(99)00149-9

DO - 10.1016/S0893-133X(99)00149-9

M3 - Article

C2 - 10788759

AN - SCOPUS:0034006867

VL - 22

SP - 595

EP - 607

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 6

ER -